Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 4.2/5
Dr Lal PathLabs Ltd (DLPL IN)
Watchlist
Contact IR
78
Analysis
Health Care
•
India
Dr. Lal PathLabs Limited operates clinical laboratories. The Company offers medical diagnostic, cardiology, radiology, pathology and imaging, health checkup, blood test, and customer care services. Dr. Lal PathLabs conducts its business in India.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
TSE Tokyo Price Index TOPIX
•
08 Aug 2024 21:52
Downgrading Japan; Stay Defensive; Downgrading Outlook on Global Equities $ACWI to Neutral
Downgrading Japan TOPIX, Nikkei; Stay Defensive; Downgrading Outlook on Global Equities $ACWI $EEM to Neutral; Many Risk-Off Signals increase odds...
Vermilion Research
Follow
227 Views
Share
bullish
•
Sun Pharmaceutical Industries
•
26 Jul 2024 20:59
Pullback Underway; Getting Defensive; Long-Term RS Bottoms for Defensives Is a Reason for Caution
Pullback Underway $ACWI $SPX; Getting Defensive; Long-Term RS Bottoms for Defensive Sectors is a Reason for Caution. Buys in Health Care,...
Vermilion Research
Follow
474 Views
Share
bullish
•
Hitachi Energy India
•
21 Jul 2024 22:52
NIFTY MIDCAP150 Index Rebalance Preview: 14 Changes & Good Performance as Actives Start Trading
There could be 14/15 changes for the NIFTY Midcap150 Index in Sep. Apart from the passive trackers, there are huge active funds tracking the index....
Brian Freitas
Follow
399 Views
Share
bullish
•
Agilus Diagnostics Limited
•
08 Feb 2024 02:16
Agilus Diagnostics Limited Pre-IPO - Still Recovering from COVID
Agilus Diagnostics Limited (SRLL IN) is looking to raise around US$200m in its upcoming India IPO. In this note, we talk about the company's past...
Sumeet Singh
Follow
602 Views
Share
bullish
•
Prodia
•
29 Dec 2023 12:00
Prodia (PRDA IJ) - Diagnosing a Return to Healthy Profits
Prodia (PRDA IJ) is significantly cheaper than its Indian comparables, trading on half the valuation, despite being a high-quality player tapping...
Angus Mackintosh
Follow
673 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x